SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:kth-277187"
 

Search: id:"swepub:oai:DiVA.org:kth-277187" > (2020) > Genome-Scale Metabo...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development

Larsson, Ida (author)
Uppsala universitet,Neuroonkologi,Science for Life Laboratory, SciLifeLab,KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.
Uhlén, Mathias (author)
KTH,Science for Life Laboratory, SciLifeLab,Systembiologi,KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.
Zhang, Cheng (author)
KTH,Science for Life Laboratory, SciLifeLab,Systembiologi,KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.
show more...
Mardinoglu, Adil (author)
KTH,Science for Life Laboratory, SciLifeLab,Systembiologi,KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.;Kings Coll London, Inst Dent, Ctr Host Microbiome Interact, London, England.
show less...
 (creator_code:org_t)
2020-04-17
2020
English.
In: Frontiers in Genetics. - : Frontiers Media SA. - 1664-8021. ; 11
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Glioblastoma (GBM) is an aggressive type of brain cancer with a poor prognosis for affected patients. The current line of treatment only gives the patients a survival time of on average 15 months. In this work, we use genome-scale metabolic models (GEMs) together with other systems biology tools to examine the global transcriptomics-data of GBM-patients obtained from The Cancer Genome Atlas (TCGA). We reveal the molecular mechanisms underlying GBM and identify potential therapeutic targets for effective treatment of patients. The work presented consists of two main parts. The first part stratifies the patients into two groups, high and low survival, and compares their gene expression. The second part uses GBM and healthy brain tissue GEMs to simulate gene knockout in a GBM cell model to find potential therapeutic targets and predict their side effect in healthy brain tissue. We (1) find that genes upregulated in the patients with low survival are linked to various stages of the glioma invasion process, and (2) identify five essential genes for GBM, whose inhibition is non-toxic to healthy brain tissue, therefore promising to investigate further as therapeutic targets.

Subject headings

NATURVETENSKAP  -- Biologi -- Biokemi och molekylärbiologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Biochemistry and Molecular Biology (hsv//eng)
NATURVETENSKAP  -- Biologi -- Genetik (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Genetics (hsv//eng)

Keyword

GBM
GEMs
genome-scale metabolic models
glioblastoma
systems biology
gelatinase A
gelatinase B
phosphatidylinositol 3
4
5 trisphosphate 3 phosphatase
protein p53
Article
brain tissue
cancer staging
cancer survival
clinical trial (topic)
drug development
extracellular matrix
gene expression
gene knockout
genome
human
RNA sequence
transcriptomics
tumor invasion
upregulation

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view